
AstraZeneca CEO Soriot said to be looking at US listing
AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – and potentially even its domicile – according to an unconfirmed media report. The Times suggests that the move is a consequence …